Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Quantum Cascade Lasers from Hamamatsu Photonics

Published: Monday, July 01, 2013
Last Updated: Monday, July 01, 2013
Bookmark and Share
QCLs for environmental gas monitoring and other applications.

Hamamatsu Photonics has produced a series of quantum cascade lasers (QCLs), offering both continuous and pulsed output in the mid-infrared region, at room temperature.

This latest technology allows Hamamatsu to fabricate different QCLs with emission wavelengths tailored anywhere from 4.8 microns to 10.6 microns.

The current lineup already features high output power at room temperature, typically 10 to 50 mW, with a very narrow spectral linewidth of 0.02 nm.

The emission wavelength of the QCL can be altered with accurate control of the operating temperature and stabilized emission is realized by use of a thermoelectric cooler.

The latest QCL technology can be offered with either a FP (Fabry Perot) or DFB (Distributed Feed Back) laser structure, depending on the customer’s requirements.

The current lineup includes lasers in both HHL and TO-8 packages and there are a range of accessories available. These include; forced air and water cooled laser mounts, pulsed QCL drivers as well as ZnSe lenses and lens adaptors.

There are many emerging applications for QCLs including high-resolution spectroscopy systems for environmental sensing and pollution monitoring, breath analysis in medical diagnosis, industrial process control and security applications such as screening for plastic explosives.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Hamamatsu Announces the Completion of a New Manufacturing Facility in Beijing
New building to expand both manufacturing capacity and R&D activities in China.
Saturday, March 29, 2014
Visiopharm and Hamamatsu Announce Worldwide OEM Agreement
Reseller partnership for quantitative digital pathology.
Monday, July 09, 2012
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!